Dextrose 10 % (D10W) – Evidence‑Based Clinical Guidelines
1. Treatment of Symptomatic Hypoglycemia in Adults
- Administer D10W intravenously in 5–10 g (50–100 mL) aliquots every 1–2 minutes until symptoms resolve, aiming for a post‑treatment glucose of 100–180 mg/dL. This rapid, titrated approach is recommended for adults who cannot take oral glucose. 1
- Calculate the initial total dextrose dose using the formula:
- The titrated dosing strategy achieves target glucose in ~98 % of patients within 30 minutes while minimizing dangerous over‑correction. 1
2. Continuous D10W Infusion Protocols
2.1. Insulin Overdose or Prolonged Hypoglycemia (Adults)
- Start a continuous D10W infusion at approximately 4.2 mL kg⁻¹ h⁻¹ (≈7 mg kg⁻¹ min⁻¹) – equivalent to 100 mL kg⁻¹ per 24 h – and titrate to keep glucose between 100–180 mg/dL. 1
2.2. Interruption of Enteral Nutrition in Diabetic Patients
- When enteral feeding is stopped in patients receiving insulin (especially type 1 diabetes), begin D10W at 50 mL h⁻¹ (5 g h⁻¹) immediately to prevent hypoglycemia. 2
2.3. Tapering and Discontinuation
- Do not abruptly stop the dextrose infusion in insulin‑overdose cases; reduce the rate by 50 % over the final 30 minutes before cessation to avoid rebound hypoglycemia. 1
3. Pediatric Dosing Regimens
- Initial bolus: Give 0.5–1.0 g kg⁻¹ of glucose as D10W (5–10 mL kg⁻¹) slowly for confirmed hypoglycemia. The lower end (0.5 g kg⁻¹) can be delivered with either 10 % or 25 % dextrose, but D10W requires a larger volume. 3
- Avoid undiluted D50W in children because its high osmolarity can cause venous irritation and sclerosis. 3
- Maintenance infusion after the bolus: Continue D10W at 100 mL kg⁻¹ per 24 h (≈7 mg kg⁻¹ min⁻¹) with appropriate electrolytes. 3
- Infants at risk of hypoglycemia should receive glucose at 4–6 mg kg⁻¹ min⁻¹ (6–8 mg kg⁻¹ min⁻¹ in newborns), typically via D10% normal saline. 3
- For conscious children who can swallow, oral glucose (15–20 g) remains the first‑line therapy. 3
4. Monitoring Requirements
- Immediate post‑treatment: Re‑measure blood glucose 15 minutes after the initial dose; additional doses are often needed. 1
- Short‑term follow‑up: Check glucose again at 60 minutes, as the effect may be transient. 1
- During ongoing infusion: Monitor glucose every 1–2 hours. [1][2]
- Electrolytes: Assess serum potassium and sodium initially every 30–60 minutes when starting a continuous infusion, because dextrose can shift electrolytes. 1
5. Safety Considerations
- Avoid reflexive full‑dose administration of concentrated dextrose; rapid, repeated boluses have been linked to cardiac arrest and hyperkalemia. Titrate dosing based on the initial glucose level and patient response. [1][2]
- In pediatric patients, excessive glucose administration should be avoided because hyperglycemia can worsen ischemic brain injury. 3
6. Special Clinical Scenarios
6.1. Diabetic Ketoacidosis (DKA)
- When serum glucose reaches 250 mg/dL during DKA treatment, switch fluids to 5 % dextrose with 0.45–0.75 % NaCl to prevent hypoglycemia while continuing insulin. 2
6.2. Hyperosmolar Hyperglycemic State (HHS)
- Add dextrose to the infusion when blood glucose falls to 300 mg/dL. 2